Similar to CPT1a inhibition, palmitate-induced energy production by CD37KO lymphoma cells was significantly diminished upon treatment with ACSL1 inhibitor compared to WT control cells (Fig. 6g). This evidence concerns the gene CPT1A and lymphoma.